Statements from the 15th International Symposium on HIV and Emerging Infectious Diseases (ISHEID), Toulon, France, May 28-30, 2008

HIV Clin Trials. 2008 Sep-Oct;9(5):348-65. doi: 10.1310/hct0905-348.

Abstract

In May 2008, 800 delegates from 64 countries met at the International Symposium on HIV and Emerging Infectious Diseases in France to discuss a list of hot topics in HIV and hepatitis viruses. This article summarizes the statements obtained from these discussions around a list of 10 of these topics: (a) antiretroviral treatment for naïve patients; (b) use of integrase inhibitors; (c) antiretrovirals in development; (d) management of lipid abnormalities; (e) hepatotoxicity of antiretroviral therapy; (f) management of hepatitis B in HIV patients; (g) management of acute hepatitis C in HIV patients; (h) outcome of HIV-HCV co-infected patients; (i) preexposure prophylaxis in HIV infection; and (j) the long road to a preventive HIV vaccine. For each topic, we reported the main data presented by speakers and summarized the results of the subsequent discussions.

Publication types

  • Review

MeSH terms

  • AIDS Vaccines / immunology
  • Animals
  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active
  • Communicable Diseases, Emerging / complications
  • Communicable Diseases, Emerging / drug therapy*
  • Communicable Diseases, Emerging / virology
  • Congresses as Topic
  • France
  • HIV / pathogenicity
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • Hepacivirus / pathogenicity
  • Hepatitis B / complications
  • Hepatitis B / drug therapy*
  • Hepatitis B / virology
  • Hepatitis B virus / pathogenicity
  • Hepatitis C / complications
  • Hepatitis C / drug therapy*
  • Hepatitis C / virology
  • Humans

Substances

  • AIDS Vaccines
  • Anti-HIV Agents